SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN) -- Ignore unavailable to you. Want to Upgrade?


To: Master (Hijacked) who wrote (172)5/5/1998 12:46:00 PM
From: Peter Silsbee  Respond to of 550
 
>> AGPH which just started HUMAN trials on an anti-angiogenesis drug- almost a year behind SUGN... and AGPH goes up 5!

Just to set the record straight, AGPH just announced the initiation of pivotal Phase II/III trials. They are not just starting human trials.

Agouron Initiates Pivotal Trials of Oral Anti-Angiogenesis Drug AG3340 for Treatment of Lung Cancer and Prostate Cancer

biz.yahoo.com

PLS, belatedly trying to catch up on SUGN.



To: Master (Hijacked) who wrote (172)5/5/1998 1:58:00 PM
From: Larry L  Read Replies (1) | Respond to of 550
 
To all: Where are you getting your info. on the upcoming WSJ article on Sugen from? Just trying to gain confirmation.